Some people are not taking weight-loss medications responsibly, the physician says, and don't realize their full implications ...

Individual usage of glucagon like peptide 1 receptor agonists reduced the risk of hospitalization due to alcohol and substance use disorders.

Metabolic dysfunction-associated steatotic liver disease (MASLD) is currently a pressing public health issue associated with ...

Fact checked by Nick Blackmer Some anti-obesity medications, including GLP-1s, may prompt people to drink less alcohol, new ...

GLP-1 agonists substantially slowed kidney deterioration and failure, independent of diabetes status. The most extensive and ...

Mangione, 26, was arrested Monday in connection with the murder of Brian Thompson outside an investor conference at a Hilton ...

Glucagon-like peptide 1 receptor agonists and fenofibrates may protect patients with type 2 diabetes against diabetic macular ...

A recent meta-analysis of 69 clinical trials found the risk for ischemic optic neuropathy from GLP-1 therapy is too low to be ...

Semaglutide use in diabetes patients is linked to a higher risk of NAION, a rare eye condition. A Danish-Norwegian study ...

What Are GLP-1s? Glucagon-like peptide-1 receptor agonists, also known as GLP-1 drugs, are a class of medications that mimic the action of ...

As drugs like Ozempic and Wegovy keep flying off the shelves, more and more people are taking the drug into their own hands ...